Natural Capsules Limited has given disclosure under Regulation 30(9) of SEBI (LODR) Regulations
NATCAPSUQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Natural Capsules Limited's material subsidiary, Natural Biogenex Private Limited (NBPL), has signed Framework & Contract Manufacturing agreements with Fermbox Bio Private Limited. Under the deal, Fermbox will use the spare capacity of NBPL's fermentation plant and will invest up to Rs. 60 Crores in its own plant and machinery, which will be placed inside NBPL's factory. The transaction is not a related-party deal, involves no share issuance, and grants no special rights such as board seats. The agreement has been disclosed under SEBI LODR Regulation 30(9) to keep the exchanges informed of material developments at the subsidiary level.
Positive for shareholders — the deal brings a Rs. 60 Crore capital infusion into NBPL's facility from a third party and unlocks idle fermentation capacity, which could translate into incremental revenue and better asset utilization for the material subsidiary and, by extension, Natural Capsules Limited.